Preclinical and clinical progress of particle-mediated DNA vaccines for infectious diseases

Methods

Volumn 40, Issue 1, 2006, Pages 86-97

  Fuller, Deborah H ^a   Loudon, Peter ^b   Schmaljohn, Connie ^c  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b PowderMed Ltd   (United Kingdom)

^c UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

Author keywords

DNA vaccine; Gene gun; Human clinical trial; Nonhuman primate; Particle mediated epidermal delivery; Swine

Indexed keywords

ANTIGEN; DNA VACCINE; GLYCOPROTEIN; NEUTRALIZING ANTIBODY; VIRUS DNA;

ANTIGEN PRESENTING CELL; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CLINICAL TRIAL; DENGUE; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG ERUPTION; DRUG SAFETY; DRUG TOLERABILITY; EBOLA VIRUS; EDEMA; EPIDEMIC ENCEPHALITIS; ERYTHEMA; FILOVIRUS; GENE GUN; HANTAVIRUS; HEPATITIS B; HEPATITIS E; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGENICITY; INFECTION; INFLUENZA; MALARIA; NONHUMAN; PRIORITY JOURNAL; PRURITUS; SKIN DISCOLORATION; SKIN MANIFESTATION; T LYMPHOCYTE; TICK BORNE ENCEPHALITIS; TICK BORNE ENCEPHALITIS FLAVIVIRUS; VIRUS HEMORRHAGIC FEVER; VIRUS INFECTION; VIRUS LOAD; VIRUS PARTICLE;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; CLINICAL TRIALS; CLINICAL TRIALS AS TOPIC; COMMUNICABLE DISEASE CONTROL; DRUG EVALUATION, PRECLINICAL; PARTICLE SIZE; SWINE; VACCINES, DNA; VIRAL VACCINES;

ANIMALIA; PRIMATES; SUS SCROFA;

EID: 33748856603     PISSN: 10462023     EISSN: 10959130     Source Type: Journal    
DOI: 10.1016/j.ymeth.2006.05.022     Document Type: Article

References (89)

1. Tang D.C., DeVit M., and Johnston S.A. Nature 356 (1992) 152-154
2. Ulmer J.B., Donnelly J.J., Parker S.E., Rhodes G.H., Felgner P.L., Dwarki V.J., Gromkowski S.H., Deck R.R., DeWitt C.M., Friedman A., et al. Science 259 (1993) 1745-1749
3. Donnelly J.J., Ulmer J.B., and Liu M.A. Life Sci. 60 (1997) 163-172
4. Liu M.A., and Ulmer J.B. Adv. Genet. 55 (2005) 25-40
5. Barouch D.H. J. Pathol. 208 (2006) 283-289
6. Calarota S.A., and Weiner D.B. Expert Rev. Vaccines 3 (2004) S135-S149
7. Garmory H.S., Brown K.A., and Titball R.W. Genet. Vaccines Ther. 1 (2003) 2
8. Manoj S., Babiuk L.A., and van Drunen Littel-van den Hurk S. Crit. Rev. Clin. Lab. Sci. 41 (2004) 1-39
9. Doria-Rose N.A., and Haigwood N.L. Methods 31 (2003) 207-216
10. Moore A.C., and Hill A.V. Immunol. Rev. 199 (2004) 126-143
11. Woodland D.L. Trends Immunol. 25 (2004) 98-104
12. Barouch D.H., Letvin N.L., and Seder R.A. Immunol. Rev. 202 (2004) 266-274
13. Calarota S.A., and Weiner D.B. Immunol. Rev. 199 (2004) 84-99
14. Scheerlinck J.Y. Vaccine 19 (2001) 2647-2656
15. Cui Z., and Mumper R.J. Crit. Rev. Ther. Drug Carrier Syst. 20 (2003) 103-137
16. O'Hagan D.T., and Rappuoli R. Pharm. Res. 21 (2004) 1519-1530
17. Pachuk C.J., McCallus D.E., Weiner D.B., and Satishchandran C. Curr. Opin. Mol. Ther. 2 (2000) 188-198
18. Yang N.S., Burkholder J., Roberts B., Martinell B., and McCabe D. Proc. Natl. Acad. Sci. USA 87 (1990) 9568-9572
19. Condon C., Watkins S.C., Celluzzi C.M., Thompson K., and Falo Jr. L.D. Nat. Med. 2 (1996) 1122-1128
20. Eisenbraun M.D., Fuller D.H., and Haynes J.R. DNA Cell Biol. 12 (1993) 791-797
21. Bennett A.M., Phillpotts R.J., Perkins S.D., Jacobs S.C., and Williamson E.D. Vaccine 18 (1999) 588-596
22. Fynan E.F., Webster R.G., Fuller D.H., Haynes J.R., Santoro J.C., and Robinson H.L. Proc. Natl. Acad. Sci. USA 90 (1993) 11478-11482
23. Garmory H.S., Freeman D., Brown K.A., and Titball R.W. Vaccine 22 (2004) 947-957
24. Hooper J.W., Kamrud K.I., Elgh F., Custer D., and Schmaljohn C.S. Virology 255 (1999) 269-278
25. Kim J.W., Hung C.F., Juang J., He L., Kim T.W., Armstrong D.K., Pai S.I., Chen P.J., Lin C.T., Boyd D.A., and Wu T.C. Gene Ther. 11 (2004) 1011-1018
26. Leitner W.W., Seguin M.C., Ballou W.R., Seitz J.P., Schultz A.M., Sheehy M.J., and Lyon J.A. J. Immunol. 159 (1997) 6112-6119
27. Trimble C., Lin C.T., Hung C.F., Pai S., Juang J., He L., Gillison M., Pardoll D., Wu L., and Wu T.C. Vaccine 21 (2003) 4036-4042
28. Kamili S., Spelbring J., Carson D., and Krawczynski K. J. Infect. Dis. 189 (2004) 258-264
29. Lodmell D.L., Ray N.B., Parnell M.J., Ewalt L.C., Hanlon C.A., Shaddock J.H., Sanderlin D.S., and Rupprecht C.E. Nat. Med. 4 (1998) 949-952
30. McCluskie M.J., Brazolot Millan C.L., Gramzinski R.A., Robinson H.L., Santoro J.C., Fuller J.T., Widera G., Haynes J.R., Purcell R.H., and Davis H.L. Mol. Med. 5 (1999) 287-300
31. Polack F.P., Lee S.H., Permar S., Manyara E., Nousari H.G., Jeng Y., Mustafa F., Valsamakis A., Adams R.J., Robinson H.L., and Griffin D.E. Nat. Med. 6 (2000) 776-781
32. Falo Jr. L.D. Proc. Assoc. Am. Physicians 111 (1999) 211-219
33. Tuting T., Storkus W.J., and Falo Jr. L.D. J. Invest. Dermatol. 111 (1998) 183-188
34. Fuller D.H., Murphey-Corb M., Clements J., Barnett S., and Haynes J.R. J. Med. Primatol. 25 (1996) 236-241
35. Fuller D.H., Simpson L., Cole K.S., Clements J.E., Panicali D.L., Montelaro R.C., Murphey-Corb M., and Haynes J.R. Immunol. Cell. Biol. 75 (1997) 389-396
36. Lu S., Arthos J., Montefiori D.C., Yasutomi Y., Manson K., Mustafa F., Johnson E., Santoro J.C., Wissink J., Mullins J.I., Haynes J.R., Letvin N.L., Wyand M., and Robinson H.L. J. Virol. 70 (1996) 3978-3991
37. Pertmer T.M., Eisenbraun M.D., McCabe D., Prayaga S.K., Fuller D.H., and Haynes J.R. Vaccine 13 (1995) 1427-1430
38. Fuller D.H., Murphey-Corb M., Barnett S., Steimer K., and Haynes J.R. Vaccine 15 (1997) 924-926
39. Lodmell D.L., Parnell M.J., Bailey J.R., Ewalt L.C., and Hanlon C.A. Vaccine 20 (2001) 838-844
40. Schmaljohn C., Custer D., VanderZanden L., Spik K., Rossi C., and Bray M. Virology 263 (1999) 166-174
41. Doria-Rose N.A., Pierce C.C., Hensel M.T., Sutton W.F., Sheikh N., Polacino P., Kuller L., Zhu Y.D., Hu S.L., Anderson D., and Haigwood N.L. J. Med. Primatol. 32 (2003) 218-228
42. Tanabayashi K., Mukai R., Yamada A., Takasaki T., Kurane I., Yamaoka M., Terazawa A., and Konishi E. Vaccine 21 (2003) 2338-2345
43. Hengge U.R., Walker P.S., and Vogel J.C. J. Clin. Invest. 97 (1996) 2911-2916
44. Doria-Rose N.A., Ohlen C., Polacino P., Pierce C.C., Hensel M.T., Kuller L., Mulvania T., Anderson D., Greenberg P.D., Hu S.L., and Haigwood N.L. J. Virol. 77 (2003) 11563-11577
45. Locher C.P., Sykes K.F., Blackbourn D.J., and Johnston S.A. J. Med. Primatol. 31 (2002) 323-329
46. Putkonen P., Quesada-Rolander M., Leandersson A.C., Schwartz S., Thorstensson R., Okuda K., Wahren B., and Hinkula J. Virology 250 (1998) 293-301
47. Kent S.J., Zhao A., Best S.J., Chandler J.D., Boyle D.B., and Ramshaw I.A. J. Virol. 72 (1998) 10180-10188
48. Fuller D.H., Rajakumar P.A., Wilson L.A., Trichel A.M., Fuller J.T., Shipley T., Wu M.S., Weis K., Rinaldo C.R., Haynes J.R., and Murphey-Corb M. J. Virol. 76 (2002) 3309-3317
49. Fuller D.H., Rajakumar P.A., Wu M.S., McMahon C.W., Fuller J.T., Bazmi A., Trichel A.M., Allen T.M., Mothe B., Haynes J.R., Watkins D.I., and Murphey-Corb M. Virology 348 (2006) 200-215
50. Gandhi R.T., and Walker B.D. Annu. Rev. Med. 53 (2002) 149-172
51. Piazza P., Fan Z., and Rinaldo Jr. C.R. Clin. Lab. Med. 22 (2002) 773-797
52. Feltquate D., Heaney S., Webster R.G., and Robinson H.L. J. Immunol. 158 (1997) 2278-2284
53. Kwissa M., von Kampen K., Zurbriggen R., Gluck R., Reimann J., and Schirmbeck R. Vaccine 18 (2000) 2337-2344
54. Oran A.E., and Robinson H.L. J Immunol. 171 (2003) 1999-2005
55. Pertmer T.M., Roberts T.R., and Haynes J.R. J. Virol. 70 (1996) 6119-6125
56. Tanghe A., Denis O., Lambrecht B., Motte V., van den Berg T., and Huygen K. Infect. Immun. 68 (2000) 3854-3860
57. Enioutina E.Y., Visic D., and Daynes R.A. Vaccine 18 (2000) 2753-2767
58. Glenn G.M., Scharton-Kersten T., Vassell R., Mallett C.P., Hale T.L., and Alving C.R. J. Immunol. 161 (1998) 3211-3214
59. Chen D., Periwal S.B., Larrivee K., Zuleger C., Erickson C.A., Endres R.L., and Payne L.G. J. Virol. 75 (2001) 7956-7965
60. Putnak R., Fuller J., VanderZanden L., Innis B.L., and Vaughn D.W. Am. J. Trop. Med. Hyg. 68 (2003) 469-476
61. Riemenschneider J., Garrison A., Geisbert J., Jahrling P., Hevey M., Negley D., Schmaljohn A., Lee J., Hart M.K., Vanderzanden L., Custer D., Bray M., Ruff A., Ivins B., Bassett A., Rossi C., and Schmaljohn C. Vaccine 21 (2003) 4071-4080
62. Custer D.M., Thompson E., Schmaljohn C.S., Ksiazek T.G., and Hooper J.W. J. Virol. 77 (2003) 9894-9905
63. Hooper J.W., Custer D.M., Smith J., and Wahl-Jensen V. Virology 347 (2006) 208-216
64. Fuller J.T., Macklin M., Drape B., McCabe D., Swain W.F., Haynes J.R., and Widera G. In: Brown F., Burton D., Doherty P., Mekalanos J., and Norrby E. (Eds). Vaccines 97: Molecular approaches to the Control of Infectious Diseases (1997), Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY 157-161
65. Lodmell D.L., Parnell M.J., Bailey J.R., Ewalt L.C., and Hanlon C.A. Vaccine 20 (2002) 2221-2228
66. Macklin M.D., McCabe D., McGregor M.W., Neumann V., Meyer T., Callan R., Hinshaw V.S., and Swain W.F. J. Virol. 72 (1998) 1491-1496
67. Hooper J.W., Thompson E., Wilhelmsen C., Zimmerman M., Ichou M.A., Steffen S.E., Schmaljohn C.S., Schmaljohn A.L., and Jahrling P.B. J. Virol. 78 (2004) 4433-4443
68. Barfoed A.M., Kristensen B., Dannemann-Jensen T., Viuff B., Botner A., Kamstrup S., and Blixenkrone Moller M. Vaccine 22 (2004) 1395-1405
69. Roy M.J., Wu M.S., Barr L.J., Fuller J.T., Tussey L.G., Speller S., Culp J., Burkholder J.K., Swain W.F., Dixon R.M., Widera G., Vessey R., King A., Ogg G., Gallimore A., Haynes J.R., and Heydenburg Fuller D. Vaccine 19 (2000) 764-778
70. Tacket C.O., Roy M.J., Widera G., Swain W.F., Broome S., and Edelman R. Vaccine 17 (1999) 2826-2829
71. Drape R.J., Macklin M.D., Barr L.J., Jones S., Haynes J.R., and Dean H.J. Vaccine 24 (2006) 4475-4481
72. Roberts L.K., Barr L.J., Fuller D.H., McMahon C.W., Leese P.T., and Jones S. Vaccine 23 (2005) 4867-4878
73. Rottinghaus S.T., Poland G.A., Jacobson R.M., Barr L.J., and Roy M.J. Vaccine 21 (2003) 4604-4608
74. McConkey S.J., Reece W.H., Moorthy V.S., Webster D., Dunachie S., Butcher G., Vuola J.M., Blanchard T.J., Gothard P., Watkins K., Hannan C.M., Everaere S., Brown K., Kester K.E., Cummings J., Williams J., Heppner D.G., Pathan A., Flanagan K., Arulanantham N., Roberts M.T., Roy M., Smith G.L., Schneider J., Peto T., Sinden R.E., Gilbert S.C., and Hill A.V. Nat. Med. 9 (2003) 729-735
75. Talaat A.M., Lyons R., and Johnston S.A. Vaccine 20 (2001) 538-544
76. Kim T.W., Lee J.H., He L., Boyd D.A., Hung C.F., and Wu T.C. Hum. Gene Ther. 16 (2005) 26-34
77. Tachedjian M., Boyle J.S., Lew A.M., Horvatic B., Scheerlinck J.P., Tennent J.M., and Andrew M.E. Vaccine 21 (2003) 2900-2905
78. Arrington J., Braun R.P., Dong L., Fuller D.H., Macklin M.D., Umlauf S.W., Wagner S.J., Wu M.S., Payne L.G., and Haynes J.R. J. Virol. 76 (2002) 4536-4546
79. Sykes K.F., Lewis M.G., Squires B., and Johnston S.A. Vaccine 20 (2002) 2382-2395
80. Robinson H.L., Montefiori D.C., Johnson R.P., Manson K.H., Kalish M.L., Lifson J.D., Rizvi T.A., Lu S., Hu S.L., Mazzara G.P., Panicali D.L., Herndon J.G., Glickman R., Candido M.A., Lydy S.L., Wyand M.S., and McClure H.M. Nat. Med. 5 (1999) 526-534
81. Hanke T., Samuel R.V., Blanchard T.J., Neumann v.C., Allen T.M., Boyson J.E., Sharpe S.A., Cook N., Smith G.L., Watkins D.I., Cranage M.P., and McMichael A.J. J. Virol. 73 (1999) 7524-7532
82. Allen T.M., Jing P., Calore B., Horton H., O'Connor D.H., Hanke T., Piekarczyk M., Ruddersdorf R., Mothe B.R., Emerson C., Wilson N., Lifson J.D., Belyakov I.M., Berzofsky J.A., Wang C., Allison D.B., Montefiori D.C., Desrosiers R.C., Wolinsky S., Kunstman K.J., Altman J.D., Sette A., McMichael A.J., and Watkins D.I. J. Virol. 76 (2002) 10507-10511
83. Allen T.M., Vogel T.U., Fuller D.H., Mothe B.R., Steffen S., Boyson J.E., Shipley T., Fuller J., Hanke T., Sette A., Altman J.D., Moss B., McMichael A.J., and Watkins D.I. J. Immunol. 164 (2000) 4968-4978
84. Horton H., Vogel T.U., Carter D.K., Vielhuber K., Fuller D.H., Shipley T., Fuller J.T., Kunstman K.J., Sutter G., Montefiori D.C., Erfle V., Desrosiers R.C., Wilson N., Picker L.J., Wolinsky S.M., Wang C., Allison D.B., and Watkins D.I. J. Virol. 76 (2002) 7187-7202
85. Vogel T.U., Reynolds M.R., Fuller D.H., Vielhuber K., Shipley T., Fuller J.T., Kunstman K.J., Sutter G., Marthas M.L., Erfle V., Wolinsky S.M., Wang C., Allison D.B., Rud E.W., Wilson N., Montefiori D., Altman J.D., and Watkins D.I. J. Virol. 77 (2003) 13348-13360
86. Hooper J.W., Custer D.M., and Thompson E. Virology 306 (2003) 181-195
87. Barfoed A.M., Blixenkrone-Moller M., Jensen M.H., Botner A., and Kamstrup S. Vaccine 22 (2004) 3628-3641
88. Rompato G., Ling E., Chen Z., Van Kruiningen H., and Garmendia A.E. Vet. Immunol. Immunopathol. 109 (2006) 151-160
89. Beard C., Ward G., Rieder E., Chinsangaram J., Grubman M.J., and Mason P.W. J. Biotechnol. 73 (1999) 243-249